Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jun 27, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 792 $7.54
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,500 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,500 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,523 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,500 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,523 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Other acquisition or disposition -- --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,170 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 03, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Jun 03, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 9,395 $5.96
Apr 17, 2017
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 8,205 $6.32
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 4,713 $6.69

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.